Annette North, EVP, General Counsel & Secty at Turning Point Therapeutics, Inc. (TPTX), sold 45,340 shares at $125.38 ($5.7M) on 2021-02-01, disclosed to the SEC on 2021-02-02.
Open-market sale of $5.7M TPTX by EVP, General Counsel & Secty. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.58 | 1,630 | $200K | 3.5% |
| 2 | $122.58 | 1,630 | $200K | 3.5% |
| 3 | $123.49 | 10,541 | $1.3M | 22.9% |
| 4 | $123.49 | 10,541 | $1.3M | 22.9% |
| 5 | $124.41 | 3,313 | $412K | 7.2% |
| 6 | $124.41 | 3,313 |
| $412K |
| 7.2% |
| 7 | $125.38 | 500 | $63K | 1.1% |
| 8 | $126.66 | 400 | $51K | 0.9% |
| 9 | $127.83 | 900 | $115K | 2.0% |
| 10 | $128.74 | 500 | $64K | 1.1% |
| 11 | $128.74 | 500 | $64K | 1.1% |
| 12 | $129.75 | 2,860 | $371K | 6.5% |
| 13 | $130.64 | 3,752 | $490K | 8.6% |
| 14 | $130.64 | 3,752 | $490K | 8.6% |
| 15 | $131.89 | 604 | $80K | 1.4% |
| 16 | $131.89 | 604 | $80K | 1.4% |
| Total | $125.61 avg | 45,340 | $5.7M | 100% |
| Filing → |
| TPTX | SELL | 2021-06-16 | $2.1M | — | Filing → |
| TPTX | SELL | 2021-03-09 | $4.3M | — | Filing → |